Machine Learning

Fleetworthy's new Toll360 uses AI to predict, reconcile, and automatically dispute toll charges, promising significant savings and efficiency gains.

Wolters Kluwer's UpToDate again tops KLAS rankings, highlighting a major trend: integrating expert-backed patient education directly into clinical care.

A new report reveals a major shift in cybersecurity strategy as firms abandon tool sprawl for unified control, driven by AI threats and cloud complexity.

With a new CIO bringing decades of clinical and business expertise, PayForward is betting that a patient-first approach can redefine health plan solutions.

With 46% of developers distrusting AI code, Qodo 2.0's new multi-agent architecture aims to restore faith by delivering more accurate, context-aware reviews.

A new partnership is trading vague online metrics for real-world visits, proving advertising's impact and reshaping how tourist destinations spend money.

GMMB promotes digital strategist Erica Monteith and ad maker Jodi Quintero, signaling a deep investment in data-driven innovation and powerful advocacy.

The digital health giant now offers a 50+ cancer blood test, promising early detection. But experts caution on its limits and lack of FDA approval.

Mahindra's new electric SUVs are getting a brain boost with indie's AI software, going beyond crash tests to proactively monitor drivers and occupants.

New preclinical data suggests Arcellx's CAR T therapy may offer a safer profile than rivals, potentially avoiding severe neurological side effects.

With key FCC and CE certifications, Vuzix begins shipping its new AI-powered LX1 smart glasses, targeting a logistics market ripe for a tech upgrade.

A Chinese tech firm plans to bring its automated parking solutions to NYC and LA, facing a crowded market, financial hurdles, and geopolitical scrutiny.

A world-first trial for personalized mRNA vaccines offers new hope for children with aggressive brain tumors, a mission born from a father's own fight.

With multiple Best in KLAS awards, Bluesight cements its leadership in patient safety and data security. Here's why hospitals trust their solutions.

MetaVia's drug vanoglipel gets a major boost from AI modeling, validating its potential to treat complex metabolic diseases like MASH and Type 2 Diabetes.

The world's largest equipment rental firm adds a Silicon Valley AI expert to its board, signaling a major push to digitize the heavy equipment industry.

A new study reveals financial firms see big returns from AI but struggle with deployment due to poor data quality and IT complexity, forcing a major rethink.

Caribou Biosciences unveils new data showing its 'off-the-shelf' CAR-T cells achieve deep, lasting responses in lymphoma and myeloma clinical trials.

An expanded partnership aims to deliver a once-daily oral tablet for hypoparathyroidism, potentially revolutionizing treatment for thousands of patients.

Global security leader Securitas acquires OSINT platform Liferaft, signaling a bold move to fuse digital threat intelligence with physical security services.